FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4380442253> ?p ?o ?g. }

• W4380442253 endingPage "2566" @default.
• W4380442253 startingPage "2559" @default.
• W4380442253 abstract "We aim to assess the theoretical impact of the atrial flow regulator (AFR) on survival in heart failure.The prospective, multicentre, open-label, non-randomised PRELIEVE study (NCT03030274) assessed the safety and efficacy of the Occlutech AFR device in patients with symptomatic heart failure with reduced ejection fraction (HFrEF) (left ventricular ejection fraction (LVEF) ≥ 15% and <40%) or heart failure with preserved ejection fraction (HFpEF) (LVEF ≥40% and <70%) and elevated PCWP (≥15 mmHg at rest or ≥25 mmHg during exercise). In this analysis, after the first 60 patients completed 12 months of follow-up, the theoretical impact of AFR implantation on survival was assessed by comparing the observed mortality rate with the median predicted probability for one-year mortality. Each subject's risk of mortality was predicted from individual baseline data using the Meta-Analysis Global Group in Chronic HF (MAGGIC) prognostic model. A total of 87 patients (46% female, median age 69 years [IQR 62-74]) had undergone successful device implantation for the treatment of HFrEF (53%) and HFpEF (47%). Sixty patients had a complete 12 month follow-up. The median follow-up was 351 days (interquartile range [IQR] 202-370). Six (7%) patients died during follow-up (8.6 deaths per 100 patient-years; 95% confidence interval [CI] 2.7 to 15.5), all of which had HFrEF. The median predicted mortality rate for the overall study population was 12.2 deaths per 100 patient-years (95% CI 10.2 to 14.7). While the observed mortality rate (0 deaths per 100 patient-years) was significantly lower than the median predicted mortality rate (9.3 deaths per 100 patient-years; 95% CI 8.4 to 11.1) in patients with HFpEF (-9.3 deaths per 100 patient-years; 95% CI -11.1 to -8.4), there was no difference in patients with HFrEF (-3.6 deaths per 100 patient-years; 95% CI -9.5 to 3.0). Four deaths were HF-related deaths (5.7 HF-related deaths per 100 patient-years; 95% CI 1.4 to 11.9; 10.8 HF-related deaths per 100 patient-years; 95% CI 2.5 to 23.1 in the HFrEF subgroup).In patients with HFpEF, the mortality rate following AFR implantation was lower than the predicted mortality rate. Dedicated randomised, controlled trials are needed - and currently ongoing - to investigate whether the AFR improves mortality." @default.
• W4380442253 created "2023-06-14" @default.
• W4380442253 creator A5003943960 @default.
• W4380442253 creator A5005151561 @default.
• W4380442253 creator A5006796065 @default.
• W4380442253 creator A5014640185 @default.
• W4380442253 creator A5015896567 @default.
• W4380442253 creator A5017416890 @default.
• W4380442253 creator A5029674394 @default.
• W4380442253 creator A5038774828 @default.
• W4380442253 creator A5044790443 @default.
• W4380442253 creator A5049607555 @default.
• W4380442253 creator A5064995734 @default.
• W4380442253 creator A5072769960 @default.
• W4380442253 date "2023-06-13" @default.
• W4380442253 modified "2023-09-26" @default.
• W4380442253 title "Predicted impact of atrial flow regulator on survival in heart failure with reduced and preserved ejection fraction" @default.
• W4380442253 cites W1531805104 @default.
• W4380442253 cites W1961002235 @default.
• W4380442253 cites W1991463267 @default.
• W4380442253 cites W2001984572 @default.
• W4380442253 cites W2086254872 @default.
• W4380442253 cites W2103313207 @default.
• W4380442253 cites W2123494220 @default.
• W4380442253 cites W2127919322 @default.
• W4380442253 cites W2152072062 @default.
• W4380442253 cites W2156220725 @default.
• W4380442253 cites W2427094903 @default.
• W4380442253 cites W2769453207 @default.
• W4380442253 cites W2970201026 @default.
• W4380442253 cites W2971294569 @default.
• W4380442253 cites W2981125726 @default.
• W4380442253 cites W2983523827 @default.
• W4380442253 cites W3043680844 @default.
• W4380442253 cites W3128677574 @default.
• W4380442253 cites W3193297191 @default.
• W4380442253 cites W3193598686 @default.
• W4380442253 cites W3206664673 @default.
• W4380442253 cites W4210760531 @default.
• W4380442253 cites W4380442253 @default.
• W4380442253 doi "https://doi.org/10.1002/ehf2.14384" @default.
• W4380442253 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37312287" @default.
• W4380442253 hasPublicationYear "2023" @default.
• W4380442253 type Work @default.
• W4380442253 citedByCount "1" @default.
• W4380442253 countsByYear W43804422532023 @default.
• W4380442253 crossrefType "journal-article" @default.
• W4380442253 hasAuthorship W4380442253A5003943960 @default.
• W4380442253 hasAuthorship W4380442253A5005151561 @default.
• W4380442253 hasAuthorship W4380442253A5006796065 @default.
• W4380442253 hasAuthorship W4380442253A5014640185 @default.
• W4380442253 hasAuthorship W4380442253A5015896567 @default.
• W4380442253 hasAuthorship W4380442253A5017416890 @default.
• W4380442253 hasAuthorship W4380442253A5029674394 @default.
• W4380442253 hasAuthorship W4380442253A5038774828 @default.
• W4380442253 hasAuthorship W4380442253A5044790443 @default.
• W4380442253 hasAuthorship W4380442253A5049607555 @default.
• W4380442253 hasAuthorship W4380442253A5064995734 @default.
• W4380442253 hasAuthorship W4380442253A5072769960 @default.
• W4380442253 hasBestOaLocation W43804422531 @default.
• W4380442253 hasConcept C119060515 @default.
• W4380442253 hasConcept C126322002 @default.
• W4380442253 hasConcept C164705383 @default.
• W4380442253 hasConcept C179755657 @default.
• W4380442253 hasConcept C2777099384 @default.
• W4380442253 hasConcept C2778198053 @default.
• W4380442253 hasConcept C2908647359 @default.
• W4380442253 hasConcept C44249647 @default.
• W4380442253 hasConcept C71924100 @default.
• W4380442253 hasConcept C78085059 @default.
• W4380442253 hasConcept C80461066 @default.
• W4380442253 hasConcept C99454951 @default.
• W4380442253 hasConceptScore W4380442253C119060515 @default.
• W4380442253 hasConceptScore W4380442253C126322002 @default.
• W4380442253 hasConceptScore W4380442253C164705383 @default.
• W4380442253 hasConceptScore W4380442253C179755657 @default.
• W4380442253 hasConceptScore W4380442253C2777099384 @default.
• W4380442253 hasConceptScore W4380442253C2778198053 @default.
• W4380442253 hasConceptScore W4380442253C2908647359 @default.
• W4380442253 hasConceptScore W4380442253C44249647 @default.
• W4380442253 hasConceptScore W4380442253C71924100 @default.
• W4380442253 hasConceptScore W4380442253C78085059 @default.
• W4380442253 hasConceptScore W4380442253C80461066 @default.
• W4380442253 hasConceptScore W4380442253C99454951 @default.
• W4380442253 hasIssue "4" @default.
• W4380442253 hasLocation W43804422531 @default.
• W4380442253 hasLocation W43804422532 @default.
• W4380442253 hasLocation W43804422533 @default.
• W4380442253 hasOpenAccess W4380442253 @default.
• W4380442253 hasPrimaryLocation W43804422531 @default.
• W4380442253 hasRelatedWork W2051712573 @default.
• W4380442253 hasRelatedWork W2061321770 @default.
• W4380442253 hasRelatedWork W2077083067 @default.
• W4380442253 hasRelatedWork W2316342240 @default.
• W4380442253 hasRelatedWork W2789205885 @default.
• W4380442253 hasRelatedWork W2965474825 @default.
• W4380442253 hasRelatedWork W3033076790 @default.
• W4380442253 hasRelatedWork W4200030969 @default.

• next